Acadian Asset Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.85M Buy
262,147
+3,069
+1% +$38.3K ﹤0.01% 851
2025
Q4
$3.34M Buy
259,078
+50,170
+24% +$644K 0.01% 763
2025
Q3
$2.69M Buy
208,908
+156,383
+298% +$2.09M ﹤0.01% 815
2025
Q2
$929K Buy
52,525
+47,596
+966% +$829K ﹤0.01% 995
2025
Q1
$87K Buy
+4,929
New +$112K ﹤0.01% 1371
2024
Q4
Sell
-8,712
Closed -$136K 2010
2024
Q3
$136K Buy
+8,712
New +$158K ﹤0.01% 1494
2024
Q2
Sell
-3,143
Closed -$49K 1864
2024
Q1
$49K Sell
3,143
-39,554
-93% -$582K ﹤0.01% 1384
2023
Q4
$634K Buy
42,697
+37,319
+694% +$499K ﹤0.01% 970
2023
Q3
$85K Buy
+5,378
New +$155K ﹤0.01% 1336
2021
Q1
Sell
-3,091
Closed -$536K 2239
2020
Q4
$536K Buy
3,091
+2,026
+190% +$277K ﹤0.01% 1216
2020
Q3
$119K Sell
1,065
-1,067
-50% -$85.3K ﹤0.01% 1610
2020
Q2
$126K Buy
2,132
+109
+5% +$7.17K ﹤0.01% 1654
2020
Q1
$137K Buy
2,023
+775
+62% +$61.2K ﹤0.01% 1283
2019
Q4
$105K Buy
+1,248
New +$101K ﹤0.01% 1438

Other funds holding NVCR